Trial reportThe Psychiatric quarterly2004
Depression, anxiety, anger, and somatic symptoms in patients with body dysmorphic disorder.
Trial report in The Psychiatric quarterly, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 81 citations in OpenAlex.
- "Tattoo Characteristics and Testing for Body Dysmorphic Disorder: An Internet-based Self-questionnaire Survey of 4,809 Individuals with Tattoos".Acta dermato-venereologica · 2024Article
- Prevalence of Body Dysmorphic Disorder (BDD) among the Lebanese University students: associated risk factors and repercussion on mental health.Journal of preventive medicine and hygiene · 2023Article
- Body Dysmorphic Disorder Questionnaire-Dermatology Version (BDD-DV): formation and validation of the Polish language version.Postepy dermatologii i alergologii · 2023Article
- Magnitude and determinants of body dysmorphic disorder among female students in Saudi public secondary schools.Journal of Taibah University Medical Sciences · 2019Article
- Body dysmorphic disorder in patients attending a dermatology clinic in Nigeria: sociodemographic and clinical correlates.Anais brasileiros de dermatologia · 2019Article
- Article
- A comparison study of body dysmorphic disorder versus social phobia.Psychiatry research · 2013Article
- A review of body dysmorphic disorder and its presentation in different clinical settings.The primary care companion for CNS disorders · 2013Review
- Cognitive-behavioral therapy for youth with body dysmorphic disorder: current status and future directions.Child and adolescent psychiatric clinics of North America · 2011Review
- Pharmacotherapy for Body Dysmorphic Disorder.Psychiatric annals · 2010Article
- Body dysmorphic disorder: some key issues for DSM-V.Depression and anxiety · 2010Review
- Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V?Depression and anxiety · 2010Review
- Treating body dysmorphic disorder with medication: evidence, misconceptions, and a suggested approach.Body image · 2008Review
- Cosmetic surgery and psychological issues.Psychiatry (Edgmont (Pa. : Township)) · 2007Article
- Suicidality in Body Dysmorphic Disorder.Primary psychiatry · 2007Article
- Clinical features and correlates of major depressive disorder in individuals with body dysmorphic disorder.Journal of affective disorders · 2007Article
- Delusional versus nondelusional body dysmorphic disorder: clinical features and course of illness.Journal of psychiatric research · 2006Article
- Body dysmorphic disorder and other clinically significant body image concerns in adolescent psychiatric inpatients: prevalence and clinical characteristics.Child psychiatry and human development · 2006Article
- The demystification of autoscopic phenomena: experimental propositions.Current psychiatry reports · 2005Review
- Pharmacotherapy for body dysmorphic disorder: treatment received and illness severity.Annals of clinical psychiatry : official journal of the American Academy of Clinical PsychiatristsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
Abstract
Body dysmorphic disorder (BDD) is a relatively common and impairing disorder. However, little is known about non-BDD symptoms and well-being in patients with this disorder. Seventy-five outpatients with DSM-IV BDD completed the Symptom Questionnaire, a validated self-report measure with four scales: depression, anxiety, somatic/somatization, and anger-hostility. Scores were compared to published norms for normal subjects and psychiatric outpatients. Participants in an open-label fluvoxamine trial completed the Symptom Questionnaire at baseline and endpoint. Compared to normal controls, BDD subjects had markedly elevated scores on all four scales, indicating severe distress and psychopathology. Compared to psychiatric patients, BDD subjects had higher scores on the depression, anxiety, and anger/hostility scales but not on the somatic/somatization scale. Scores on all scales significantly decreased with fluvoxamine. In conclusion, patients with BDD have markedly high levels of distress, are highly symptomatic, and have poor well-being in the domains of depression, anxiety, somatic symptoms, and anger-hostility. All of these symptoms significantly improved with fluvoxamine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.